Ledger.Open graph →
SEC Form D · filed June 2, 2016

Arch Therapeutics, Inc

Offering
$3.5M
Sold
$3.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
FRAMINGHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Terrence W. Norchi · Framingham, MAExec · DirectorJames R. Sulat · Framingham, MADirectorAvtar W. Dhillon · Framingham, MADirectorRichard E. Davis · Framingham, MAExecTerrence W. Norchi · Natick, MAExec · DirectorJames R. Sulat · Framingham, MADirectorAvtar W. Dhillon · Framingham, MADirectorRichard E. Davis · Boston, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗